2007
DOI: 10.1007/s00436-006-0416-4
|View full text |Cite
|
Sign up to set email alerts
|

The use of Trichuris suis and other helminth therapies to treat Crohn’s disease

Abstract: Infections with gastrointestinal (GI) nematodes are prevalent worldwide, despite the fact that anti-helminthic medications are regarded as safe, efficient, and widely available globally. In this review, we highlight the potential therapeutic benefits that may be realized through the clinical use of Trichuris suis and other helminths for Crohn's disease (CD). Long-lived helminthic parasites are remarkable in their ability to down-regulate host immunity, protecting themselves from elimination, and also minimize … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
37
0

Year Published

2008
2008
2019
2019

Publication Types

Select...
5
3
2

Relationship

1
9

Authors

Journals

citations
Cited by 48 publications
(37 citation statements)
references
References 39 publications
0
37
0
Order By: Relevance
“…Do some GI tracts posses a bacterial community that is suppressive toward pathogenic fungi, a phenomenon seen in the soil ecosystem (Borneman and Becker, 2007)? What are the potential roles eukaryotes may play in immune stimulation and modulation; for example, the role of yeasts and the presence of anti-S-cerevisiae antibodies in Crohn's disease (Schaffer et al, 2007) and the use of certain helminths as a treatment for CD (Reddy and Fried, 2007)?…”
Section: Discussionmentioning
confidence: 99%
“…Do some GI tracts posses a bacterial community that is suppressive toward pathogenic fungi, a phenomenon seen in the soil ecosystem (Borneman and Becker, 2007)? What are the potential roles eukaryotes may play in immune stimulation and modulation; for example, the role of yeasts and the presence of anti-S-cerevisiae antibodies in Crohn's disease (Schaffer et al, 2007) and the use of certain helminths as a treatment for CD (Reddy and Fried, 2007)?…”
Section: Discussionmentioning
confidence: 99%
“…IL-13 secretion by cells of the innate or adaptive immune system might thus contribute to provide antimicrobial protection, reinforce the mucosal barrier and maintain host-microbial homeostasis. The described effect might contribute to the clinical success of helminth therapy in patients with Crohn's disease [54]. On the other hand, reduced mucosal IL-13 levels in the absence of continuous Th2-mediated immune stimulation due to improved hygiene conditions and a lower prevalence of helminth infections in industrialized countries might lead to alterations in the enteric microbiota, particularly of the infant population, and in turn predispose to inflammatory and autoimmune diseases [55,56].…”
Section: Discussionmentioning
confidence: 99%
“…Secondly, the lack of helminth induced immunomodulation in the human populations of the industrialised countries has been hypothesised to contribute to the steep increase in autoimmune diseases, such as inflammatory bowel disease, type 1 diabetes, and multiple sclerosis (reviewed by McKay, 2006;Elliott et al, 2007;Zaccone et al, 2007;Fleming, 2011). This 'Helminth Hypothesis' (Elliott et al, 2007) is derived from the original 'Hygiene Hypothesis' of Strachan (1989), and T. suis is one of the favourites for potential medical use (Reddy and Fried, 2007). T. suis was, among other criteria, originally selected because the infections are self-eliminating in man and the larvae are non-migratory (Elliott et al, 2007).…”
Section: Immune Responses and Immunomodulationmentioning
confidence: 99%